Advertisement

Topics

Recce submits additional information to FDA for synthetic antibiotic

06:23 EST 15 Feb 2018 | Manufacturing Chemist

Recce Pharmaceuticals, the company developing a new class of synthetic antibiotics, announced it has submitted additional data to the US Food and Drug Administration, including an additional communication request

Original Article: Recce submits additional information to FDA for synthetic antibiotic

NEXT ARTICLE

More From BioPortfolio on "Recce submits additional information to FDA for synthetic antibiotic"

Advertisement
Quick Search
Advertisement
Advertisement